Litigation Details for Cubist Pharmaceuticals LLC v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2020)
✉ Email this page to a colleague
Cubist Pharmaceuticals LLC v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-03-24 |
Court | District Court, N.D. West Virginia | Date Terminated | 2021-11-05 |
Cause | 35:271 Patent Infringement | Assigned To | Irene Patricia Murphy Keeley |
Jury Demand | None | Referred To | |
Patents | 9,138,456 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Cubist Pharmaceuticals LLC v. Mylan Pharmaceuticals Inc.
Biologic Drugs cited in Cubist Pharmaceuticals LLC v. Mylan Pharmaceuticals Inc.
Details for Cubist Pharmaceuticals LLC v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2021-11-04 | 127 | Other Document | and (ii) the term “Patents-in-Suit” shall mean United States Patent Numbers 9,138,456 and 8,835,382. …or replaced) with respect to the Patents-in-Suit or any other patent listed in the FDA’s Orange Book … 3. Until expiration of the Patents-in-Suit, Mylan, including any of its Affiliates…successors and assigns, is enjoined from infringing the Patents-in-Suit, on its own part | External link to document |
2021-11-05 | 128 | Judgment - Consent | ii) the term “Patents-in-Suit” shall mean United States Patent Numbers 9,138,456 and 8,835,382.…or replaced) with respect to the Patents-in-Suit or any other patent listed in the FDA’s Orange Book … 3. Until expiration of the Patents-in-Suit, Mylan, including any of its Affiliates…successors and assigns, is enjoined from infringing the Patents-in-Suit, on its own part | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |